Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
08/2012
08/14/2012US8242341 Plants and seeds of corn variety CV599033
08/14/2012US8242339 Plants and seeds of hybrid corn variety CH604406
08/14/2012US8242336 Maize variety inbred PH11SY
08/14/2012US8242335 Sweet pepper hybrid 9927864
08/14/2012US8242329 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
08/14/2012US8242328 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
08/14/2012US8242255 Antisense oligonucleotides against cPLA2, compositions and uses thereof
08/14/2012US8242253 Nucleotide sequence of shrimp actin promoter and its use in genetic transformation biotechnology
08/14/2012US8242245 Fetal polypeptides from human liver
08/14/2012US8242091 for a disorder of a subject's heart involving loss of cardiomyocytes by administering an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart; Vitamin D3 Up-Regulated Protein-1; peroxiredoxin
08/14/2012US8242074 Modulation of the amount or function of pathogenic CD14+CD16+ monocytes
08/14/2012US8241914 EPI-damage apparatus and methods for sorting particles
08/14/2012US8241909 Method for manufacturing glycoproteins having human-type glycosylation
08/14/2012US8241908 Extracellular matrix coated surface for culturing cells
08/14/2012US8241907 Synthetic surfaces for culturing stem cell derived cardiomyocytes
08/14/2012US8241906 Magnetic manipulation of biological samples
08/14/2012US8241905 Preparing three-dimensional biocompatible matrix for propagation of preferential tissues; regenerative medicine and organ replacement
08/14/2012US8241904 System and method for controlling a mammalian cell culture process
08/14/2012US8241903 Catecholamine receptor modulation
08/14/2012US8241902 Preparation of adult stem cell-derived connective tissue progenitors
08/14/2012US8241900 mpl ligand
08/14/2012US8241899 Anti-TNF antibodies, compositions, methods and uses
08/14/2012US8241898 Regenerative dot cells
08/14/2012US8241897 Isolation of neural stem cells using gangliosides and other surface markers
08/14/2012US8241892 Method and apparatus for holding cells
08/14/2012US8241888 microorganism capable of making an isoprenoid by changing the carbon flux through geranyl pyrophosphate, farnesyl pyrophosphate, or geranylgeranyl pyrophosphate and synthesis of isopentenyl pyrophosphate from an isoprenoid pathway; production of farnesol and geranylgeraniol
08/14/2012US8241871 Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof
08/14/2012US8241848 Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues
08/14/2012US8241652 Spherical particles; casting three-dimensional structures; mixing emulsifier into aqueous solution containing gelatin; mixing with solvent; solidification; wound healing agents
08/14/2012US8241642 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
08/14/2012US8241628 Compositions and methods for antibodies targeting complement protein C5
08/14/2012US8241622 Adeno-associated virus vectors with intravector heterologous terminal palindromic sequences
08/14/2012US8241621 Using t-regulatory cells (Tregs) derived from adipose tissue, bone marrow and cord blood for treatment of autoimune diseases
08/14/2012US8241198 Ventricular assist device capable of implantation of stem cells
08/14/2012CA2604693C Multi-cryopreserved hepatocyte compositions and methods for their preparation
08/14/2012CA2522747C Method of detecting native probnp with a monoclonal antibody binding to the amino acids 38-43
08/14/2012CA2514971C Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene
08/14/2012CA2489212C Marker for stem cells and its use
08/14/2012CA2458514C Modified cry3a toxins and nucleic acid sequences coding therefor
08/14/2012CA2457485C Combination motif immune stimulatory oligonucleotides with improved activity
08/14/2012CA2442300C Cd8.alpha. + lymphoid dendritic cell differentiated from human hematopoietic stem cell and a method for differentiation
08/14/2012CA2441994C Composition and methods for the production of biological tissues and tissue constructs
08/14/2012CA2429954C Method for altering cell fate
08/14/2012CA2407905C Antibodies capable to selectively detect prion prpsc isoforms
08/14/2012CA2404679C Adenine binding g-protein coupled receptors
08/14/2012CA2373274C Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
08/14/2012CA2351396C Bioengineered tissue constructs and methods for producing and using them
08/14/2012CA2283476C Men1, the gene associated with multiple endocrine neoplasia type 1, menin polypeptides, and uses thereof
08/13/2012CA2780843A1 Pharmaceutically compatible method for purifying intact bacterial minicells
08/09/2012WO2012106670A2 Expandable liquid volume in an led bulb
08/09/2012WO2012106669A2 Foxc1 antibodies and methods of their use
08/09/2012WO2012106459A1 Synthetic substrate for stem cell culture and methods of use thereof
08/09/2012WO2012106393A2 Withanolide isolated from physalis longifolia and analogs and methods of use thereof
08/09/2012WO2012106367A2 Pluripotent stem cells and method of stimulating and extracting non-embryonic pluripotent stem cells from mammal blood and using reconstituted pluripotent stem cells to treat diseases including chronic obstructive pulmonary disease
08/09/2012WO2012106321A1 Acetyl co-enzyme a carboxylase herbicide resistant plants
08/09/2012WO2012105983A1 Selective 3d biopatterning
08/09/2012WO2012105979A1 3d trophoblast matrix for preparing organ-specific stem cells
08/09/2012WO2012105699A1 Method for production of antibody having high complement-dependent biological activity
08/09/2012WO2012105630A1 Method for testing diseases associated with lipid metabolism, and method for assessment of prophylactic and/or therapeutic agent for diseases associated with lipid metabolism
08/09/2012WO2012105616A1 Peptide library
08/09/2012WO2012105505A1 Highly functional liver cells derived from pluripotent stem cells, method for producing same, and method for testing metabolism/toxicity of drug
08/09/2012WO2012105495A1 Phenylpyruvate reductase and method for manufacturing optically-active phenyllactic acid and 4-hydroxyl-phenyllactic acid using same enzyme
08/09/2012WO2012104988A1 Enzyme and method of production therefor
08/09/2012WO2012104987A1 Enzyme and method of production therefor
08/09/2012WO2012104936A1 Method for culturing human pluripotent stem cells
08/09/2012WO2012104437A1 Bioreactor for cell culture on a three-dimensional substrate
08/09/2012WO2012104400A1 Novel method for the production of differentiated respiratory epithelial cells
08/09/2012WO2012103594A1 Barley with modified ssiii
08/09/2012WO2012051210A3 Mesenchymal stem cells and related therapies
08/09/2012WO2012027470A3 Articles of manufacture and methods for modeling chinese hamster ovary (cho) cell metabolism
08/09/2012WO2011129756A8 Methods and combination
08/09/2012US20120204292 Stress resistant plants
08/09/2012US20120204291 Stress tolerant plants
08/09/2012US20120204290 Agronomically elite lettuce with quantitative bremia lactuca resistance
08/09/2012US20120204289 Manipulation of flavonoid biosynthetic pathway
08/09/2012US20120204285 Rice Cultivar Designated 'CL261'
08/09/2012US20120204283 Spearmint Plant Mentha spicata L. Denominated KI-MsEM0042
08/09/2012US20120204281 Drg11-responsive (dragon) gene family
08/09/2012US20120204280 Drg11-responsive (dragon) gene family
08/09/2012US20120204279 Polynucleotide derived from novel hepatitis c virus strain and use thereof
08/09/2012US20120204278 Animal models and therapeutic molecules
08/09/2012US20120204277 Non-Aggregating Fluorescent Proteins and Methods for Using the Same
08/09/2012US20120204276 Methods related to a mutation in complement factor h-related protein 5 in patients with glomerulonephritis
08/09/2012US20120204275 Apoe immunotherapy
08/09/2012US20120204273 Compositions relating to a phosphoprotein and methods of use
08/09/2012US20120203714 Systems for Growing Phototrophic Organisms Using Green Energy
08/09/2012US20120203016 High Oleic Imidazolinone Resistance Sunflower
08/09/2012US20120202985 Hyper IgE Animal Model with Enhanced Immunoglobulin Heavy Chain Class Switching to C-epsilon
08/09/2012US20120202876 Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
08/09/2012US20120202874 Antisense oligonucleotide modulation of stat3 expression
08/09/2012US20120202871 Cationic lipids and methods for the delivery of therapeutic agents
08/09/2012US20120202814 Compounds with ddx3 inhibitory activity and uses thereof
08/09/2012US20120202799 Condensed Azepine Derivatives As Bromodomain Inhibitors
08/09/2012US20120202763 Methods for treating cancer and non-neoplastic conditions
08/09/2012US20120202751 Methods of monitoring endoplasmic reticulum (er) stress response
08/09/2012US20120202750 Inhibitors of iap
08/09/2012US20120202748 Recombinant mussel adhesive protein fp-131
08/09/2012US20120202745 Adult cerebellum-derived neural stem cells and compositions and methods for producing oligodendrocytes
08/09/2012US20120202741 Delivery of bmp-7 and methods of use thereof
08/09/2012US20120202732 Modified aav capsid polypeptides
1 ... 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 ... 1827